CD8A and neoplasm: Apart from NK cells, which are the dominant mediators in hybrid resistance against parental tumors in the initial phase of tumor implantation, CD4 T cells and CD8 T cells can also recognize tumor-specific antigens in the subsequent stages of tumor progression.